News

Engimmune Therapeutics Announces the Appointment of Dr Annalisa D’Andrea to its Board of Directors

Leading industry expert with more than 25 years of experience…

Serca Pharmaceuticals showcases exciting data on 13-M at Heart Failure 2023

First-in-class, cardioprotective drug with potential to transform…

AMSilk to join panel at SynBioBeta Global Synthetic Biology Conference

Munich, Germany, 17 May, 2023: AMSilk GmbH (“AMSilk”), the…

Vicore to host webcast with updated AIR trial results after presentation at the ATS congress

Webcast to be held on: May 26, 2023 at 08:00 EST/14:00 CET Stockholm,…

Peer-Reviewed Translational Research Paves The Way For First-In-Class Autotaxin Inhibitor IOA-289 In Cancer

Amsterdam, The Netherlands and Geneva, Switzerland, 16 May 2023 -…

Acesion Pharma Announces Positive Pre-Clinical Data for AP31969

Copenhagen, Denmark – Acesion Pharma (“Acesion” or “the…

Vicore strengthens its Board of Directors

Stockholm, May 12, 2023 – Vicore Pharma Holding AB (STO: VICO)…

BII appointed by the Danish government to run international deep tech start-up accelerator

BioInnovation Institute (BII), an international non-profit foundation…

STIMULAN® now available in South Africa to treat bacterial infection

Novus Healthcare will exclusively distribute STIMULAN® and genex…

Verona Pharma Reports First Quarter 2023 Financial Results and Provides Corporate Update

NDA submission on schedule for Q2 2023 12 abstracts and one…

Neuraxpharm rebrands Laboratorios Lesvi as Neuraxpharm Pharmaceuticals S.L.

Laboratorios Lesvi is Neuraxpharm’s manufacturing facility…

BII-startups pursue US expansion opportunities through TMC BioBridge

Texas Medical Center (TMC) and the BioInnovation Institute (BII)…

iOnctura Expands Pipeline And Receives Development Grant From Health Holland And KWF

Licensing deal gives iOnctura exclusive global development…

Vicore initiates clinical proof-of-concept study of endothelial dysfunction

Stockholm, May 3, 2023 – Vicore Pharma Holding AB (STO:…

We’d love to hear from you

For more information about Optimum Strategic Communications, please get in touch.

© Optimum Strategic Communications.